2.230USD+9.31%Mkt Cap: 15.66M $P/E: —2d ago
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacryla…